DarioHealth is partnering with Dexcom to integrate the company's continuous glucose monitors into Dario's chronic-condition management platform.
The collaboration will allow Dario's digital health tools for metabolic health to include data from Dexcom CGMs, wearable sensors that automatically monitor blood glucose levels for patients with diabetes.
Dario said integrating CGM data would provide...
Dexcom announced last week that its G7 continuous glucose monitoring system has received FDA clearance.
The latest model of its CGM, which can be used by people with all types of diabetes ages 2 and up, is expected to launch in the U.S. early next year. As the company works out insurance coverage for the G7, it plans to offer cash payment options for early adopters.
The CGM fits on the back of...
At the J.P. Morgan Healthcare Conference this week, Dexcom, maker of continuous glucose monitoring systems, made waves after CEO Kevin Sayer announced new clinical trial data from its yet to be released CGM, the G7.
The 308 person trial demonstrated that the G7's mean absolute relative difference (MARD) was 8.2% for adults and 8.1% for pediatric patients. The G7 was submitted to the FDA in the...
Garmin announced a suite of apps that will allow people with diabetes who use the Dexcom G6 continuous glucose monitor (CGM) to view glucose levels and trends on their smartwatch.
The Dexcom Connect IQ apps allow users with a compatible smartwatch or cycling computer to view their glucose levels as well as a three-hour history to get a better picture of where their levels may be headed during the...
Third-party digital health companies can now integrate Dexcom’s continuous glucose monitoring data into their platforms and devices in real-time thanks to a new FDA clearance for the company’s Partner Web APIs.
The data integration capabilities are available to companies on an invite-only basis. So far, wearable device-maker Garmin and chronic-condition-management company Livongo have entered the...
Diabetes care has changed dramatically in recent years, thanks to technological developments, but some of the metrics used in the disease’s management remain outdated. That’s why Dexcom created The Global Movement for Time in Range, an educational campaign to raise awareness and adoption of time in range as the standard of care in diabetes management.
Time in range is the percentage of time spent...
Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products.
The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche.
Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the...
Despite coming out on top of analysts’ revenue predictions, Dexcom’s stock is tumbling after the company shared its first quarter of 2021 financial results.
As of Friday afternoon, Dexcom’s stock has fallen 6.3% from about $422 to $395.
Still, the company posted year-over-year growth for Q1 and increased its expectations for the remainder of the year.
“Dexcom is off to a great start in 2021,...
Dr. Amy Abernethy, Principal Deputy Commissioner and Acting Chief Information Officer at the FDA, will be stepping down from her positions at the agency in mid-to-late April, according to a memo Acting FDA Commissioner Dr. Janet Woodcock sent out to agency staff this morning.
Abernethy came to the agency in early 2019 following a long line of executive and board positions at healthcare and health...
Dexcom, a medtech device company best known for its continuous glucose monitoring systems, is launching a new venture fund aimed at investing in adjacent businesses.
Called Dexcom Ventures, the new investor will be zeroing in on sensing technology, data analytics, remote patient monitoring and population health. In fact, the new venture is expected to fund companies working in glucose sensing...
_9.JPG?itok=VEqiJYvP)
.jpg?itok=BD5G-Yu_ "Shaking Hands")
_8_0.jpeg?itok=7-3NDPpQ)
.jpg?itok=n4N5nDjy)
